The rise in prevalence of chronic diseases due to various medical and physical conditions among the population globally is expected to support the growth of global monoclonal antibody custom service market
Meridian Market Consultants (MMC) has published a new report titled, “2020-2025 Global and Regional Monoclonal Antibody Custom Service Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report (Enhanced Version)”
Global monoclonal antibody custom service market, By Product (Rat Custom Monoclonal Antibody, Rabbit Custom Monoclonal Antibody), By Application (Diagnostic Application, Therapeutic Application, Protein Purification), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2020 and 2025.
As per the report, the rise in prevalence of chronic diseases such as cancer among the population across the world is majorly driving the growth of the global monoclonal antibody custom service market.
Basically, Antibodies are proteins generated by plasma cells in response to specific antigens, and are used for diagnostic and therapeutic purposes. Monoclonal antibodies are artificially produced antibodies that are formed by clone immune cells which are all exact duplicates of a unique parent cell.
Monoclonal antibodies can have monovalent resemblance where they are bound to the common epitope, which refer to the portion of an antigen which can be recognized by the antibody. Contradictory, polyclonal antibodies are usually made by several different plasma cells and are bound to more than one epitope lineages.
The increasing R&D activities and technological advancements in the pharmaceutical and biotechnological research laboratories is also boosting the growth of the global monoclonal antibody custom service market.
Additionally, the increase in rate of approval for therapeutic antibodies by regulatory authorities across the world is also playing its role in giving a positive push to the growth of the global monoclonal antibody custom service market.
Moreover, the growing expenditure in the research and development activities by governments all across the world as well as pharmaceutical and biotechnology companies is also augmenting the growth of the global monoclonal antibody custom service market.
In addition to that, the upsurge in patent expiry of prevalent monoclonal antibodies and growing acceptance of targeted immunotherapy across the world is also positively fueling the growth of the global monoclonal antibody custom service market.
Furthermore, few other factors which are positively impacting the growth of the global monoclonal antibody custom service market are elevating consciousness among patients and physicians with respect to the applications of monoclonal antibody therapy, disclosure of advanced products, rising acceptance of therapeutic antibodies in cost-sensitive markets across the world, and swift authorization by key regulatory authorities for progressive therapies.
Remarkably, the increasing research & development by the prominent players of the global market are driving the growth of the monoclonal antibody custom service market.
MMC Study identifies some of the key participating players in the monoclonal antibody custom service market globally are Thermo Fisher Scientific, GenScript, Abnova Corporation, Creative-Biolabs, Abcam, ProMab Biotechnologies, and Envigo, among others.
About Meridian Market Consultants:
Meridian Market Consultants (MMC) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.